Category Specific RSS

Categories: News

Ambitious Nanoveu preparing to sell $50m of phone accessories

Phone accessories company Nanoveu (ASX: NVU) is seeking to ride the wave of public interest in hygiene products, appointing U.S-based sales and marketing firm D360 to sell its antiviral smartphone screen and case protection products through North America. 

Whilst such an appointment would normally be standard practice for FMCG manufacturers, Nanoveu’s appointment centres around performance Options to be distributed to D360 if the firm can reach lofty targets ranging from USD $2.5m in sales up to $50m for the phone accessories. 

“It is an important time in the development of Nanoveu’s antiviral product as we approach the important milestone of first sales,” said Nanoveu Chairman and CEO, Alfred Chong. 

“I am thrilled to be partnering with the D360 team, who will be able to bring a wealth of sales experience to assist in the launch of our unique antiviral phone protection product.”

Within the partner appointment, remuneration for D360 will be up to 3,250,000 performance Options with an exercise price of $0.20, expiring on 31 December 2023. To receive the full allotment, D360 must achieve USD $50 million by the end of 2022 but partial payment milestones are included along the way at $2.5m, $5m and $20m. 

Shares in NVU last traded at $0.09 with the company listing on the ASX in 2018 with an IPO offer price of $0.20. 

Interest in Nanoveu has been sparked over previous weeks with the Company reporting that it had developed an antiviral phone protector. Upon testing at an independent U.S lab, their phone accessories proved to eradicate 99.99% of a coronavirus strain within 30 minutes of contact. 

Nanoveu has since secured regulatory approval from Therapeutic Goods Association (TGA) to market the product in Australia and is aiming to commence sales shortly. 

If D360 can meet their performance targets up to $50 million in phone accessory sales, it would be an incredible effort from all involved at Nanoveu which reported total sales of AUD $18,000 for the quarter ending 31 March 2020. It follows on from the $61,023  in revenue generated through CY2019. 

“D360 experts bring significant real-world experience across digital media, consumer electronics and e-commerce which enable clients to have a solid playbook on how to build and launch a product or service effectively,” said D360 Partner, David Cook. 

Alfred Chan

Alfred Chan is a Business Reporter at The Sentiment specialising in ASX-listed small cap companies, a bloodstock enthusiast and former equities analyst.

Recent Posts

Atomo Locks in US$410K Pascal Order as FebriDx Demand Accelerates in the US

Atomo Diagnostics (ASX:AT1) has secured a significant new order for its patented Pascal cassette, with…

1 week ago

June 2025 quarter CPI no roadblock to August RBA rate cut

The June 2025 quarter CPI data released today were cheered by mortgage holders and share…

2 weeks ago

Vection Secures $7.3M Defence Extension as AI Demand Strengthens

AI Gains Ground in Defence Sector As governments increase investment in defence technology, AI-powered tools…

2 weeks ago

Calix Secures $44.9m ARENA Grant to Build Green Iron Plant with ZESTY Technology

Calix Limited (ASX:CXL) has taken a significant leap forward in developing Australia’s low-emissions steel value…

3 weeks ago

Harris Technology boosts retail margins in FY25 through growth of refurbished tech

Online tech retailer Harris Technology (ASX: HT8) has delivered a strong lift in gross product…

3 weeks ago

Lumos Diagnostics Secures US$317M Deal to Distribute FebriDx® in U.S.

In a significant move set to reshape rapid diagnostics in the U.S., ASX-listed Lumos Diagnostics…

4 weeks ago